Blueprint
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C.
20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of
Report (date of earliest event reported): July 10,
2018
|
Colorado
|
|
001-11889
|
|
84-0916344
|
|
(State or
other jurisdiction of incorporation)
|
|
(Commission
File No.)
|
|
(IRS Employer
Identification No.)
|
8229 Boone
Boulevard. Suite 802
Vienna, Virginia 22182
(Address of
principal executive offices, including Zip Code)
Registrant’s
telephone number, including area code: (703) 506-9460
N/A
(Former name or
former address if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant
under any of the following provisions:
☐
Written
communications pursuant to Rule 425 under the Securities Act (17CFR
230.425)
☐
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b)
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-14c))
Indicate
by check mark whether the registrant is an emerging growth company
as defined in Rule 405 of the Securities Act of 1933 (§203.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of
1934 (§204.12b-2 of this chapter.
Emerging
growth company ☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Item
3.03.
Material
Modification to Rights of Security Holders.
On July
10, 2018 the Company extended the expiration date of its Series DD
and Series EE warrants to December 10, 2018. The Series DD and
Series EE warrants were issued on December 8, 2016. As a result of
the reverse stock split approved by the Company’s
shareholders and adopted by the Company’s
directors,
●
the holders of the
Series DD warrants are entitled to purchase 1,360,960 shares of the
Company’s common stock at an exercise price of $4.50 per
share, and
●
the holders of the
Series EE warrants are entitled to purchase 1,360,960 shares of the
Company’s common stock at an exercise price of $4.50 per
share
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
Date:
July 10, 2018 |
CEL-SCI
CORPORATION
|
|
|
|
|
|
|
|
|
By:
|
/s/
Geert
Kersten
|
|
|
|
|
Geert
Kersten |
|
|
|
|
Chief
Executive Officer
|
|